• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Mesa Laboratories Inc.

    10/2/25 6:46:04 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 10)


    MESA LABORATORIES INC

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    59064R109

    (CUSIP Number)


    09/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    59064R109


    1Names of Reporting Persons

    BlackRock, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    373,374.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    378,897.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    378,897.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.9 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    MESA LABORATORIES INC
    (b)Address of issuer's principal executive offices:

    12100 W 6TH AVE Lakewood CO 80228
    Item 2. 
    (a)Name of person filing:

    BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
    (b)Address or principal business office or, if none, residence:

    BlackRock, Inc., 50 Hudson Yards New York, NY 10001
    (c)Citizenship:

    See Item 4 of Cover Page
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    59064R109
    Item 4.Ownership
    (a)Amount beneficially owned:

    378897
    (b)Percent of class:

    6.9  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    373374

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    378897

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of MESA LABORATORIES INC. No one person's interest in the common stock of MESA LABORATORIES INC is more than five percent of the total outstanding common shares.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Exhibit 99
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    BlackRock, Inc.
     
    Signature:Spencer Fleming
    Name/Title:Managing Director
    Date:10/02/2025
    Exhibit Information

    Exhibit 24: Power of Attorney Exhibit 99: Item 7

    Get the next $MLAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/7/2025$67.00Underweight → Equal Weight
    Wells Fargo
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mesa Laboratories upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Mesa Laboratories from Underweight to Equal Weight and set a new price target of $67.00

    8/7/25 7:05:04 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Wells Fargo initiated coverage on Mesa Laboratories with a new price target

    Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

    8/28/24 7:48:06 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

    1/4/24 8:29:10 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO

    LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down as President and CEO on April 12, 2026, and will enable a smooth leadership transition. "Gary has served as Mesa's CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the maturation of the company's foundation, and the implementation of The Mesa Way business system," said John Sullivan, Chair of the Board. "We are grateful for his leadership and wish him continued success." T

    3/9/26 4:30:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense

    LAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced a renewed commitment to advancing primary standard calibration technology through its DryCal product line, as occupational health and safety professionals confront rising regulatory scrutiny and a generational workforce transition that threatens the integrity of workplace exposure monitoring. Across industries from pharmaceutical manufacturing to construction, worker safety depends on the accuracy of air sampling pumps used to measure exposure to hazardous substances. Those pump

    2/18/26 9:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Labs Announces Third Quarter Results

    LAKEWOOD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter ("3Q26") ended December 31, 2025 (amounts in thousands). 3Q26 Financial Summary – (comparisons are versus the same year ago period Revenues increased 3.6%Non-GAAP organic and core organic revenues1 growth was 3.6% and 1.2%, respectivelyNon-GAAP organic revenues growth excluding CG China revenues (entirely diagnostics) was 5.7%Operating income increased 38.0% to $7,975 Non-GAAP adjusted operating income ("AOI") exclu

    2/3/26 8:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    SEC Filings

    View All

    Mesa Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    3/23/26 4:25:24 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    3/9/26 5:02:29 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Mesa Laboratories Inc.

    10-Q - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    2/3/26 8:01:28 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladiwala Shiraz Shabanali bought $252,805 worth of shares (3,500 units at $72.23), increasing direct ownership by 70% to 8,523 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 5:43:24 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Capone Mark Christopher bought $99,331 worth of shares (1,301 units at $76.35), increasing direct ownership by 61% to 3,429 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:46:59 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Tripeny R Tony bought $99,940 worth of shares (1,315 units at $76.00), increasing direct ownership by 32% to 5,398 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:39:49 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladiwala Shiraz Shabanali bought $252,805 worth of shares (3,500 units at $72.23), increasing direct ownership by 70% to 8,523 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 5:43:24 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Capone Mark Christopher bought $99,331 worth of shares (1,301 units at $76.35), increasing direct ownership by 61% to 3,429 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:46:59 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Tripeny R Tony bought $99,940 worth of shares (1,315 units at $76.00), increasing direct ownership by 32% to 5,398 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:39:49 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    View All

    Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO

    LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down as President and CEO on April 12, 2026, and will enable a smooth leadership transition. "Gary has served as Mesa's CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the maturation of the company's foundation, and the implementation of The Mesa Way business system," said John Sullivan, Chair of the Board. "We are grateful for his leadership and wish him continued success." T

    3/9/26 4:30:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Mesa Laboratories Appoints Mark Capone to its Board of Directors

    LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

    1/8/24 8:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Financials

    Live finance-specific insights

    View All

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

    1/7/26 5:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    Lakewood, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2025, to shareholders of record at the close of business on November 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in

    10/3/25 11:01:27 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, inc

    7/3/25 12:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    10/15/24 1:29:56 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    2/13/24 5:09:39 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    1/23/24 2:18:26 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials